In 1883 was created Cincinnati Childrenu2019s, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Cincinnati.
The fund is constantly included in less than 2 deals per year. This Cincinnati Childrenu2019s works on 18 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2014. The higher amount of exits for fund were in 2016.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Pharmaceutical, Bioinformatics. Among the various public portfolio startups of the fund, we may underline Enable Injections, Claritas Genomics, Airway Therapeutics
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cincinnati Childrenu2019s, startups are often financed by CincyTech, Partisan Management Group, Allos Ventures. The meaningful sponsors for the fund in investment in the same round are CincyTech, Queen City Angels, Danmar Capital. In the next rounds fund is usually obtained by CincyTech, Sequoia Capital, Queen City Angels.
Related Funds
| Fund Name | Location |
| Beihou Yijiu Investment Management | Beijing, Beijing, China |
| Blue Otus | - |
| Bonsal Capital | Baltimore, Maryland, United States |
| Dewin E-Commerce | China, Hangzhou, Zhejiang |
| DreamPlus | Seoul, Seoul-t'ukpyolsi, South Korea |
| enowa AG | - |
| Gains Associates | France, Ile-de-France, Paris |
| GeneChem Inc. | Daejeon, South Korea, Taejon-jikhalsi |
| Groundbreak Ventures | Canada, Ontario, Toronto |
| InterVest | Kirkland, United States, Washington |
| LUMA Capital Partners | New York, New York, United States |
| Midwood Investment & Development | New York, New York, United States |
| Pobox | - |
| PRONEXUS | Japan, Tokyo |
| QuestMark Partners | Baltimore, Maryland, United States |
| Shuangliang Capital | - |
| Tin Men Capital | Central Region, Singapore, Singapore |
| Weichai Power | China, Shandong, Weifang |
| WestView Capital Partners | Boston, Massachusetts, United States |
| Yadu Corporation | Delhi, India, New Delhi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hippocratic AI | $53M | 18 Mar 2024 | California, Maryland, United States | ||
STAQ Pharma | 02 Mar 2022 | Denver, Colorado, United States | |||
Enable Injections | $215M | 27 Jan 2022 | Cincinnati, Ohio, United States | ||
Airway Therapeutics | $15M | 05 Dec 2019 | Cincinnati, Ohio, United States | ||
Enable Injections | $50M | 25 Oct 2018 | Cincinnati, Ohio, United States | ||
Airway Therapeutics | $10M | 13 Mar 2018 | Cincinnati, Ohio, United States | ||
Enable Injections | $30M | 05 Oct 2016 | Cincinnati, Ohio, United States | ||
Claritas Genomics | $15M | 26 Jan 2015 | Cambridge, Massachusetts, United States | ||
Airway Therapeutics | $4M | 10 Sep 2014 | Cincinnati, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hippocratic AI | $53M | 18 Mar 2024 | California, Maryland, United States | ||
STAQ Pharma | 02 Mar 2022 | Denver, Colorado, United States | |||
Enable Injections | $215M | 27 Jan 2022 | Cincinnati, Ohio, United States | ||
Airway Therapeutics | $15M | 05 Dec 2019 | Cincinnati, Ohio, United States | ||
Enable Injections | $50M | 25 Oct 2018 | Cincinnati, Ohio, United States | ||
Airway Therapeutics | $10M | 13 Mar 2018 | Cincinnati, Ohio, United States | ||
Enable Injections | $30M | 05 Oct 2016 | Cincinnati, Ohio, United States | ||
Claritas Genomics | $15M | 26 Jan 2015 | Cambridge, Massachusetts, United States | ||
Airway Therapeutics | $4M | 10 Sep 2014 | Cincinnati, Ohio, United States |
